glp-1 research papers Current Insights, Advantages and Challenges of Small Molecule Glucagon-like Peptide 1 Receptor Agonists: A Scoping Review The anti-inflammatory and immunological properties

Its a non-ablative resurfacing treatment that requires little to no downtime. Guillen also shares a similar sentiment: My favorite treatment for hand rejuvenation has to be BBL

Studies consistently show that bed elevation reduces nighttime reflux episodes by 60% to 70%

Studies like the STEP-1 trial found that up to 39% of the weight lost on semaglutide (the compound in Ozempic and Wegovy) came from lean mass including muscle

A GLP-1 friendly label is good in theory, but its bulls***

Effectiveness: In a study of 2,539 adults with obesity or overweight plus at least one weight-related medical condition (excluding diabetes), the average weight loss at 72 weeks was 15% with 5 mg weekly doses of tirzepatide, 19.5% with 10 mg doses, and almost 21% with 15 mg doses

Past studies show that as much as 17% of GLP-1 users may be non-responders to the medication